yes but deep UG refractory gold with a low recovery rate. High Capex with AISC margin too small for financiers to take the risk and the POG going forward is uncertain.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%